Clinical trial
Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft…
NCT00004194 · Jonsson Comprehensive Cancer Center, Other · Unknown status
Key facts
| NCT number | NCT00004194 |
|---|---|
| Title | Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease |
| Official title | A Phase I-II Study for the Treatment of Steroid Resistant GVHD With Fludarabine |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Graft Versus Host Disease |
| Intervention type | Drug |
| Interventions | fludarabine phosphate |
| First posted | Sep 16, 2004 |
| Last update posted | Dec 18, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: